Suppr超能文献

血管紧张素IV通过核因子-κB途径对炎症反应的调节扩展了肾素血管紧张素系统在心血管疾病中的作用。

The regulation of the inflammatory response through nuclear factor-kappab pathway by angiotensin IV extends the role of the renin angiotensin system in cardiovascular diseases.

作者信息

Ruiz-Ortega Marta, Esteban Vanesa, Egido Jesús

机构信息

Cellular Biology in Renal Diseases Laboratory, Fundación Jiménez Diaz, Universidad Autónoma Madrid, Spain 28040.

出版信息

Trends Cardiovasc Med. 2007 Jan;17(1):19-25. doi: 10.1016/j.tcm.2006.10.003.

Abstract

The renin angiotensin system (RAS) participates in the pathogenesis of cardiovascular diseases. Although angiotensin II has been considered the effector peptide of RAS, accumulating evidence shows that other RAS peptides also posses important functions, some of them involved in cardiovascular pathology. Many studies support the importance of N-terminal angiotensin degradation product, angiotensin IV (AngIV), in the fields of cognition, renal metabolism, and pathophysiologic conditions. The novel data discussed here show that AngIV could contribute to cardiovascular damage. Angiotensin IV can be generated by degradation of angiotensin II, by aminopeptidase (AP) N, or by other proteases, which could be activated during tissue damage, suggesting that elevated AngIV levels can be found in pathologic conditions. Angiotensin IV binds to a specific receptor, AT(4), which has recently been identified as an insulin-regulated AP. In vascular cells, correspondence between AT(4) binding sites and insulin-regulated AP has been described. Angiotensin IV regulates cell growth in cardiac fibroblasts, endothelial cells, and vascular smooth muscle cells (VSMCs). In VSMC, AngIV, through AT(4), independently of AT(1) and AT(2) receptors, activates the nuclear factor-kappaB pathway and up-regulates several nuclear factor-kappaB-related genes, including the monocyte chemokine monocyte chemoattractant protein-1, the adhesion molecule intercellular adhesion molecule-1, and the cytokines interleukin 6 and tumor necrosis factor alpha. These data indicate that AngIV could be involved in the vascular inflammatory response. Thus, in endothelial cells and VSMC, AngIV up-regulates plasminogen activator inhibitor-1 expression and could participate in thrombus formation. These results reveal novel concepts of RAS in the cardiovascular system, suggesting that AngIV could play an active role in vascular diseases.

摘要

肾素血管紧张素系统(RAS)参与心血管疾病的发病机制。尽管血管紧张素II一直被认为是RAS的效应肽,但越来越多的证据表明,其他RAS肽也具有重要功能,其中一些与心血管病理有关。许多研究支持N端血管紧张素降解产物血管紧张素IV(AngIV)在认知、肾脏代谢和病理生理状况等领域的重要性。此处讨论的新数据表明,AngIV可能导致心血管损伤。血管紧张素II可通过氨肽酶(AP)N或其他蛋白酶降解生成AngIV,这些蛋白酶可能在组织损伤时被激活,这表明在病理状况下可发现AngIV水平升高。血管紧张素IV与一种特定受体AT(4)结合,该受体最近被鉴定为胰岛素调节的氨肽酶。在血管细胞中,已描述了AT(4)结合位点与胰岛素调节的氨肽酶之间的对应关系。血管紧张素IV调节心脏成纤维细胞、内皮细胞和血管平滑肌细胞(VSMC)的细胞生长。在VSMC中,AngIV通过AT(4),独立于AT(1)和AT(2)受体,激活核因子-κB途径并上调几个与核因子-κB相关的基因,包括单核细胞趋化因子单核细胞趋化蛋白-1、黏附分子细胞间黏附分子-1以及细胞因子白细胞介素6和肿瘤坏死因子α。这些数据表明,AngIV可能参与血管炎症反应。因此,在内皮细胞和VSMC中,AngIV上调纤溶酶原激活物抑制剂-1的表达,并可能参与血栓形成。这些结果揭示了RAS在心血管系统中的新概念,表明AngIV可能在血管疾病中发挥积极作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验